Grants and Contributions:
Title:
SARS-CoV-2 Point of Care Test Development
Agreement Number:
-
Agreement Value:
$1,067,880.00
Agreement Date:
Jun 18, 2020 - Jun 30, 2021
Description:
This project is to develop and qualify a rapid Point-of-Care diagnostic test for the SARS-CoV-2 virus that causes Covid-19. The test will be run on a portable reader that will be capable of operating in a clinic or in the field using a battery power source.
Organization:
National Defence
Location:
Toronto, Ontario, CA M9W 4Z4
Reference Number:
032-2020-2021-Q4-00011
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Type:
For-profit organization
Amendment Date
Mar 29, 2021
Recipient's Operating Name:
Custom Biologics
Recipient's Legal Name:
MJMG Holdings Inc.
Federal Riding Name:
Etobicoke North
Federal Riding Number:
35029
Program:
Innovation for Defence Excellence and Security Program
Amendments: